USFDA issues 13 observations after inspection of Lupin arm's Somerset facility
Published 10 Nov, 2020
By Staff Reporter
Drug firm Lupin on Monday said the US health regulator has issued 13 observations after inspection of its subsidiary''s Somerset facility in New Jersey.